Tongjitang Chinese Medicines Company Files Going-Private Transaction Statement on Schedule 13E-3 With US Securities …
Tongjitang Chinese Medicines Company , a leading specialty pharmaceutical company focusing on the development, manufacturing, marketing and selling of modernized traditional Chinese medicine in China, today announced that it has filed a going-private transaction statement on Schedule 13E-3 with the United States Securities and Exchange Commission .

Read more on PR Newswire via Yahoo! Finance